Takeda sets vote date, aims to close $62 billion Shire deal on January 8

LONDON (Reuters) - Takeda Pharmaceutical will seek investor backing for its $62 billion (47.92 billion pounds) acquisition of London-listed Shire next month and aims to close the deal on Jan. 8, the Japanese drugmaker said on Monday.The deal would be the biggest-ever overseas acquisition by a Japanese company. It needs two-thirds support from shareholders, some of whom are worried about the enlarged company's resulting debt burden.Takeda said it would hold an extraordinary general meeting..